Overview
Biovetika develops technology for producing veterinary vaccines for use in farm animals. The company was established in 2017.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 168 days late).
- 202514/07/2026
- 202408/07/2025
- 202328/06/2024
- 202214/07/2023
- 202130/12/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Offer
- Veterinary vaccines
- Biotechnology research
- Vaccine technology development
Website technology
- Website
- WordPress
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company may be represented by a member of the management board independently. If the management board is multi-member, the company may be represented and actions may be taken on its behalf by the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Lipińskiage 56 | 2,577 | $34,805.51 | 73.0235% |
Jakub Maciej Siednienkoage 49 | 600 | $8,103.73 | 17.002% |
Others | 352 | $4,754.19 | 9.9745% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2018-01-25 to 2025-01-13.
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $212,051.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $49$49 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $93$93 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $140$140 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InventionbioS.A. | $17,762,977.76 | inventionbio.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| BioceltixS.A. | $616,315.97 | bioceltix.com | ||
| VET Cell Techsp. z o.o. | $483,439.81 | vetcelltech.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| SN Biotech Technologiessp. z o.o. + limited partnership | $144,861.78 | snbiotech.com | ||
| Resolvisp. z o.o. | $335.91 | resolvi.pl | ||
| Labfarmsp. z o.o. | $13.65 | labfarm.pl | ||
| Meritrosp. z o.o. | $0.05 | meritro.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-04-25 | Share capital increase (76,450.00 PLN → 176,450.00 PLN) | |
| 2017-11-30 | Entered in the register |
FAQ
Last updated: 2026-07-17